An overview of the GHMonitorSM, a registry of children treated with Saizen® somatropin [recombinant hGH for injection]

Pediatric Endocrinology Reviews

Volumn 2, Issue SUPPL. 3, 2005, Pages 324-326

  Blethen, Sandra L ^a,b   O'Brien, Fanny ^a   Reinhart, Rosann ^a  

^a EMD SERONO INC   (United States)

^b Metab Endocrinol/N Amer (MENA)   (United States)

Author keywords

Demographics; Diagnosis; Growth hormone; Somatropin; Treatment

Indexed keywords

HUMAN GROWTH HORMONE;

ADOLESCENT; ARTICLE; BODY HEIGHT; CHILDHOOD DISEASE; CLINICAL PRACTICE; CRANIOPHARYNGIOMA; DEMOGRAPHY; DISEASE SEVERITY; EPIPHYSIOLYSIS; FEMALE; FOLLOW UP; GROWTH RETARDATION; HEADACHE; HUMAN; INJECTION SITE REACTION; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; OUTCOMES RESEARCH; SCHOOL CHILD; SCOLIOSIS; SIDE EFFECT; STATISTICAL ANALYSIS; STUNTING SYNDROME; VOMITING; CHILD; GROWTH DISORDER; REGISTER; REVIEW;

CHILD; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; REGISTRIES;

EID: 16344388959     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Graves DA. Utility of the National Cooperative Growth Study database for safety monitoring. J Pediatr 1996;128(5 Pt 2):S1-S3
2. FDA Manual of Policies and Procedures, CDER, MAPP 6010. 2, Procedures for Tracking and Reviewing phase 4 Commitments, Office of Review Management, Oct 1, 1996
3. Mills JL, Schonberger LB, Wysowki DK, Brown P, Durako SJ, Cox C, Kong F, Fradkin JE. Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients. J Pediatr 2004;144:430-436
4. August GP, Lippe, BM, Blethen SL, Rosenfeld RG, Seelig SA, Johanson AJ, Compton PG, Frane JW, McClellan BH, Sherman BM. Growth hormone treatment in the United States: demographic and diagnostic features of 2331 children. J Pediatr 1990;116:899-903
5. Lindsay R, Feldkamp M, Harris D, Robertson J, Rallison M. Utah growth study: growth standards and the prevalence of growth hormone deficiency. J Pediatr 1994;125:29-35
6. Blethen SL, Baptista J, Kuntze J, Foley T, LaFranchi S, Johanson A. Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. J Clin Endocrinol Metab 1997;82:418-420
7. Blethen SL, Allen DB, Graves D, August G, Moshang T, Rosenfeld R. Extensive personal experience. Safety of recombinant deoxyribonucleic acid-derived growth hormone: the National Cooperative Growth Study experience. J Clin Endocrinol Metab 1996;81:1704-1710
8. Tayback SP, Dean HJ. Mortality in Canadian children with growth hormone (GH) deficiency receiving GH therapy 1967-1992. The Canadian Growth Hormone Advisory Committee. J Clin Endocrinol Metab 1996;81:1693-1696